- Report
- October 2023
- 270 Pages
China
From €3867EUR$4,000USD£3,324GBP
- Report
- October 2023
- 135 Pages
China
From €1740EUR$1,800USD£1,496GBP
The Cefetamet market is a segment of the antibiotics market, which is composed of drugs used to treat bacterial infections. Cefetamet is a broad-spectrum cephalosporin antibiotic, which is used to treat a wide range of bacterial infections. It is commonly used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections. Cefetamet is also used to prevent infections in patients undergoing surgery.
Cefetamet is available in both oral and injectable forms, and is typically administered in combination with other antibiotics. It is generally well-tolerated, with few side effects. However, it is important to note that Cefetamet should not be used in patients with a history of anaphylaxis or severe allergic reactions to other cephalosporin antibiotics.
Some companies in the Cefetamet market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more